AAAAAA

   
Results: 1-10 |
Results: 10
SAFETY AND TOLERABILITY OF THE FREE-RADICAL SCAVENGER OPC-14117 IN HUNTINGTONS-DISEASE
Authors: SHOULSON I PENNEY J KIEBURTZ K OAKES D CHASE T CHOI D MARDER K MOSKOWITZ C ZUBIN N VENTURA P FEIGIN A HICKEY C COMO P RICHARD IH GOLDSTEIN J HERSCH S BISSEYBLACK C JONES R SWENSON M BELL J PAULSEN JS SWENSON A TAWFIKREEDY Z ORME C PLUMB S RUDOLPH A CLAUDE K MCMULLEN N DAY D MARSHALL FJ BOURGEOIS K WATTS A TARIOT PN JACKSON WJ HALL WJ MADDREY W BIZIERE K JAFFE M
Citation: I. Shoulson et al., SAFETY AND TOLERABILITY OF THE FREE-RADICAL SCAVENGER OPC-14117 IN HUNTINGTONS-DISEASE, Neurology, 50(5), 1998, pp. 1366-1373
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DEPRENYL AND THIOCTIC ACID IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED COGNITIVE IMPAIRMENT
Authors: SACKTOR N KIEBURTZ K SCHIFITTO G MCDERMOTT M BOURGEOIS K PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L PLUMB S RUDOLPH A KAMP C EPSTEIN L MARDER K ALBERT S DOONEIEF G STERN Y TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T MAYEUX R SACKTOR N SELNES O HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR J OSULLIVAN J SHOULSON I OAKES D REICHMAN R
Citation: N. Sacktor et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DEPRENYL AND THIOCTIC ACID IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED COGNITIVE IMPAIRMENT, Neurology, 50(3), 1998, pp. 645-651
ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS
Authors: KIEBURTZ K SHOULSON I FAHN S MCDERMOTT M KOLLER W LEWITT P NUTT J KURTH M BREWER M LEW M WELSH M WATERS C BENNETT J ROSTRUFFNER E FEIGIN A GARDINER I KURLAN R HAMMERSTAD J STONE C JANKOVIC J BEACH J TETRUD J KELKER K STANDAERT DG GROWDON JH TENNIS M GRAEFE K MARK MH KELLY SJ PAHWA R MCGUIRE D HUBBLE J FACTOR SA BROWN DL TUITE P SIME E LANG DL GREENE P WINFIELD H PAULSON G ZOOG K WEEKS C SHULTS C FONTAINE D JUNCOS JL WOOD C SHANNON K JAGLIN JA TORNABENE J LANNON MC DAVIES R FRIEDMAN J TARIOT PN HALL WJ HERNDON R PFEIFFER RF PLUMB S CASACELI C RANDOLPH H BEHMAN H CONNORTON J DAY D RUDOLPH A PELUSIO R GUTHRIE B CLAUDE K ORME C BAKER D NOBEL R IRVINE C WATTS A GORDIN A HEIKKINEN H RITA H
Citation: K. Kieburtz et al., ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS, Annals of neurology, 42(5), 1997, pp. 747-755
NITROCARBURIZING - OPTIMUM OXIDE THICKNESS
Authors: PLUMB S
Citation: S. Plumb, NITROCARBURIZING - OPTIMUM OXIDE THICKNESS, Heat treatment of metals, 24(2), 1997, pp. 49-49
A PROSPECTIVE, QUANTITATIVE STUDY OF THE NATURAL-HISTORY OF FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) - IMPLICATIONS FOR THERAPEUTIC TRIALS
Authors: TAWIL R GRIGGS RC MCDERMOTT MP COS L PERSONIUS KE LANGSAM A PANDYA S MARONIAN A SASS A MCCOY K BROWER CA PLUMB S MARTENS W HERR BE FORRESTER J FIGLEWICZ D MENDELL JR KISSEL J RAINEY F DOWNING K KING WM
Citation: R. Tawil et al., A PROSPECTIVE, QUANTITATIVE STUDY OF THE NATURAL-HISTORY OF FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) - IMPLICATIONS FOR THERAPEUTIC TRIALS, Neurology, 48(1), 1997, pp. 38-46
EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M SHOULSON I FAHN S BRIN M GOETZ C LANG A OLANOW CW LEWITT P MISTURA K WATERS C WELSH M RODNITZKY R DOBSON J ARGATOFF P TANNER C LEWIS P WATTS R BRYAN B COMELLA C JAGLIN JA SHULTS C FONTAINE D BRESSMAN SB MOSKOWITZ C HURTIG HI SHALLOW K HUBBLE J BARTER R BENNETT JP ROSTRUFFNER E PERLMUTTER JS MCGEEMINNICH L HAUSER R GAUGER L RAJPUT AH SUTTON A TRINIDAD K GARDINER IF SINGER C SHELDON C FINK JS TENNIS M BAKER D BOURGEOIS K CASACELI C CLAUDE K HICKEY G NOBEL R OAKES D ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH P SOTACK J WATTS A TARIOT PN GOLBE LI MILLER P HALL WJ HERNDON R DORFLINGER E MYL D MODI M OARSLEY L YOO K ELIAHOU E SHIMOUN G COLLETTA S SIEGEL J PEDDER S DUPUIS D
Citation: K. Kieburtz et al., EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE, Annals of neurology, 40(1), 1996, pp. 99-107
IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA
Authors: SHOULSON I FAHN S OAKES D LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K KOLLER W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K SUCHOWERSKY O BRIN MF BRESSMAN SB WEINER WJ SANCHEZRAMOS J JANKOVIC J HOEHN M TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY MM SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K BAKER D CASACELI C EBERLY S MCDERMOTT M NOBEL R ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH H SOTACK J WATTS A
Citation: I. Shoulson et al., IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA, Annals of neurology, 39(1), 1996, pp. 29-36
SCHOOL PROBLEMS IN TOURETTES-SYNDROME
Authors: ABWENDER DA COMO PG KURLAN R PARRY K FETT KA CUI L PLUMB S DEELEY C
Citation: Da. Abwender et al., SCHOOL PROBLEMS IN TOURETTES-SYNDROME, Archives of neurology, 53(6), 1996, pp. 509-511
FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) - DESIGN OF NATURAL-HISTORY STUDY AND RESULTS OF BASE-LINE TESTING
Authors: TAWIL R MCDERMOTT MP MENDELL JR KISSEL J GRIGGS RC COS L PERSONIUS K PANDYA S MARTENS B PLUMB S HERR BE MOXLEY RT STORVICK D RAINEY F KING W
Citation: R. Tawil et al., FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) - DESIGN OF NATURAL-HISTORY STUDY AND RESULTS OF BASE-LINE TESTING, Neurology, 44(3), 1994, pp. 442-446
A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M SHOULSON I OAKES D FAHN S LANG A PENNEY JB RODNITZKY R SHULTS C TANNER C TETRUD J GORDON M LEWITT P BENNETT J KOLLER W FRIEDMAN JH KURLAN R OBRIEN C MARK MH WEINER WJ SANCHEZRAMOS J PAULSON G COMELLA C JANKOVIC J OLANOW W SHANNON K LEWIS P WINFIELD L CIECIERSKI K MISTURA K LANDOW E DIETRICH S GEBHARDT AM BARTER R KENNEDY D CULLEN KA GARDINER IF BERGEN M PATTERSON V FABRIELE M SHELDON C CORNELIUS L DUDTE K THELEN JA DUNNE C GAUGER L MALAPIRA T COURVILLE K TROTTER H PELUSIO RM RUDOLPH A CASACELI C MILLER C BOETTRICH C CONNORTON J BYRNE L ORME C BORDWELL K MCMANUS J SOTACK J RANDOLPH H KAVANAUGH B BAKER D RUMFOLA L NOBEL R EBERLY S PLUMB S WATTS A GERWITZ K DARCY S EVANS P FREDERICK D DELLAPENA L SINGLETARY V TARIOT P BELL E GRIGGS RC HALL WJ HERNDON R MARSDEN CD CHASE TN COHEN G FLEISS J JACOBS L MOSS AJ MELAMED E DORFLINGER E YOO K SHIMOUN G MORAWSKY L
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347
Risultati: 1-10 |